EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structure of Human adenovirus 7 virus-like particles, a platform for developing nanotherapeutics and studying capsid assembly

Kiyano Madoo, Ryan Mazboudi, Zubaida Marufee Islam iD, Jonathan Luo iD, Robert A Kuschner, Paul Gottlieb iD, John J Dennehy iD, Rinat R Abzalimov, Jose M Galarza iD, Reza Khayat iD

Proceedings of the National Academy of Sciences · 23.06.2026 · 123 (25)

DOI: 10.1073/pnas.2526969123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 16.06.2026. Verfasst von Kiyano Madoo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The City College of New York at The City University of New York, New York, NY 10031. Hauptthemen laut MEDLINE: Capsid, Capsid Proteins, Vaccines, Virus-Like Particle, Adenoviruses, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of General Medical Sciences (NIGMS), Simons Foundation (SF), DOD | Department of Defense Education Activity (DoDEA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenoviridae family members routinely infect humans, exhibit significant genetic diversity, and are associated with a variety of illnesses. Types 4 and 7 frequently circulate in the United States and are major causes of respiratory disease. Infections can result in hospitalization and, in severe cases, death. Although a live wild-type-virus vaccine targeting these two types exists, its use is restricted to military personnel due to concerns about viral-shedding and potential for genetic recombination. To overcome these limitations, we recently developed a virus-like particle (VLP) platform as an alternative vaccination strategy. These VLPs are stable, lack genomic material, and elicit a potent humoral immune response in mice, effectively neutralizing adenoviral infection. Here, we describe the cryo-EM structure of adenovirus 7 (AdV-7) VLPs. Structural insights are essential to ensure that neutralizing antigens displayed on the VLPs accurately mimic those of the virion, guide the design of particles with improved stability and efficacy, and enable engineering of VLPs with antigenic properties targeting multiple adenovirus types. The structure shows that hexon, penton, pIIIa, pVI, pVIII, and IX assemble comparable to AdV-5, hexon and penton neutralizing epitopes are appropriately displayed for antibody recognition, penton insertion into the hexon shell promotes cement protein pIIIa to increase its interaction with the peripentonal hexons, and presence of the core-genome is associated with increased interaction between cement protein pVIII and hexon. Finally, limited proteolysis and mass spectrometry demonstrate that VLP incorporated hexons digest more readily than virion incorporated hexons, indicating the greater dynamic nature of the VLP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapsidCapsid ProteinsVaccines, Virus-Like ParticleAdenoviruses, HumanVirus AssemblyHumansCryoelectron MicroscopyAnimalsVirionAntibodies, NeutralizingMiceAntibodies, Viral

Stichwörter der Autor:innen

Adenoviruscryo-EMvaccine developmentvirus-like particles

Substanzen

Capsid ProteinsVaccines, Virus-Like ParticleAntibodies, NeutralizingAntibodies, Viral

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, The City College of New York at The City University of New York, New York, NY 10031.
  • TechnoVax, Inc. Kinnelon, NJ 07405.
  • Biotherapeutics Discovery, Boehringer-Ingelheim Pharmaceutical Inc., Ridgefield, CT 06877.
  • Biology Department, Queens College of The City University of New York, Flushing, NY 11367.
  • Biology Doctoral Program, The Graduate Center of The City University of New York, New York, NY 10016.
  • Capsidvax, Arlington, VA 22201.

ORCID-Profile: Zubaida Marufee Islam, Jonathan Luo, Paul Gottlieb, John J Dennehy, Jose M Galarza, Reza Khayat

Förderung

  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • Simons Foundation (SF)
  • DOD | Department of Defense Education Activity (DoDEA)

Zitieren

APA

Madoo, K., Mazboudi, R., Islam, Z. M., Luo, J., Kuschner, R. A., Gottlieb, P., Dennehy, J. J., Abzalimov, R. R., Galarza, J. M., & Khayat, R. (2026). Structure of Human adenovirus 7 virus-like particles, a platform for developing nanotherapeutics and studying capsid assembly. Proceedings of the National Academy of Sciences, 123(25). https://doi.org/10.1073/pnas.2526969123

Vancouver

Madoo K, Mazboudi R, Islam ZM, Luo J, Kuschner RA, Gottlieb P, et al. Structure of Human adenovirus 7 virus-like particles, a platform for developing nanotherapeutics and studying capsid assembly. Proceedings of the National Academy of Sciences. 2026;123(25). doi:10.1073/pnas.2526969123

BibTeX
@article{Madoo2026,
  author = {Madoo, Kiyano and Mazboudi, Ryan and Islam, Zubaida Marufee and Luo, Jonathan and Kuschner, Robert A and Gottlieb, Paul and Dennehy, John J and Abzalimov, Rinat R and Galarza, Jose M and Khayat, Reza},
  title = {Structure of Human adenovirus 7 virus-like particles, a platform for developing nanotherapeutics and studying capsid assembly},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {25},
  doi = {10.1073/pnas.2526969123}
}
Kostenlos starten →